Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 1.310
-0.070 (-5.07%)
At close: Apr 16, 2025
Bio-Works Technologies AB Revenue
In the year 2024, Bio-Works Technologies AB had annual revenue of 25.47M SEK, down -41.99%. Bio-Works Technologies AB had revenue of 2.65M in the quarter ending December 31, 2024, a decrease of -82.44%.
Revenue
25.47M
Revenue Growth
-41.99%
P/S Ratio
3.48
Revenue / Employee
1.02M
Employees
30
Market Cap
106.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.47M | -18.43M | -41.99% |
| Dec 31, 2023 | 43.90M | 2.58M | 6.23% |
| Dec 31, 2022 | 41.32M | -15.04M | -26.68% |
| Dec 31, 2021 | 56.36M | 49.13M | 679.08% |
| Dec 31, 2020 | 7.23M | 1.66M | 29.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.30B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |